Mkts

Stoke Therapeutics, Inc.

NASDAQ: STOK
$27.31+0.90 (+3.41%)
As of Nov 18, 1:41 PM ET

Key statistics

Day range
25.8027.39
52-week range
22.0540.22
Today
Open26.41
Previous close27.31
Volume—
Valuation
Market cap1.72B
P/E ratio—
EPS (TTM)-3.78
Income & risk
Dividend / yield—
Beta1.38
Avg volume962.3K
Discussion

STOK News

Stories mentioning STOK from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue6,2291,40210,63213,817158,56922,6144,8944,831
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development39,67341,69537,69625,85532,67623,42422,20521,136
Sales General & Admin19,97416,02714,65312,692
Total Operating Expenses59,64762,84153,72341,11747,32936,26934,89734,173
Operating Income (Loss)(53,418)(61,439)(43,091)(27,300)111,240(13,655)(30,003)(29,342)
Interest Income3,4203,6173,4663,7922,8902,9713,5453,700
Interest Expense23.002.003.003.001.00(1.00)0.005.00
Other Expense18.00(110.00)3.0028.0028.00201.0028.00(48.00)
Pretax Income(50,003)(39,625)(23,483)114,157(26,430)(25,695)
Tax Provision0.000.00(1,278)0.001,2780.000.00
Net Income (Loss)(50,003)(57,934)(38,347)(23,483)112,879(10,482)(26,430)(25,695)
Earnings Per Share (Basic)(0.79)(0.98)(0.65)(0.40)1.95(0.19)(0.47)(0.46)
Earnings Per Share (Diluted)(0.79)(0.98)(0.65)(0.40)1.90(0.19)(0.47)(0.46)
Weighted Average Shares Outstanding (Basic)63,06459,21958,61258,35457,86354,00956,34155,766
Weighted Average Shares Outstanding (Diluted)63,06459,21958,61258,35459,39954,00956,34155,766

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About STOK

Stoke Therapeutics, Inc. (NASDAQ: STOK) is a stock listed on the Nasdaq Stock Market under the ticker symbol STOK. It last traded at $27.31 (Nov 18, 2026, 1:41 PM ET), up 3.4% on the day. That gives Stoke Therapeutics a market capitalisation of $1.7B.

Over the past 52 weeks STOK has traded between $22.05 and $40.22.

Revenue for the quarter ended Mar 31, 2026 was $6.2M; a net loss of $50.0M. Revenue was down 96.1% from $158.6M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$6.2M-$50.0M-802.7%
Dec 31, 2025$1.4M-$57.9M-4132.2%
Sep 30, 2025$10.6M-$38.3M-360.7%
Jun 30, 2025$13.8M-$23.5M-170.0%

From Stoke Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…